Market Research Report Global Cryptococcosis Industry Trends Report | Page 2

A detailed qualitative analysis of drivers and restraints, and opportunities has been
provided in the market overview section. Additionally, the section comprises clinical
trial analysis and key industry event analysis to help understand the competitive
landscape in the market. This section also provides market attractiveness analysis in
terms of geography and market share analysis by key players, thus presenting a
thorough analysis of the overall competitive scenario in the global cryptococcosis
market.
Global Cryptococcosis Market: Scope of the Study
Based on treatment, the market is segmented into Amphotericin B, Flucytosine,
Fluconazole, and other antifungals. Amphotericin B further segmented into
Amphocin, Fungizone and other products. Flucytosine further segmented into
Ancobon and other products. Fluconazole includes Diflucan and other products. In
treatment type, Flucytosine was the largest segment of the global cryptococcosis
market in terms of revenue in 2015, driven by its increasing adoption in U.S. The
market segments have been analyzed based on cost-effectiveness of the drugs,
prevalence of the diseases, and growing diagnosis rate of cryptococcosis across the
globe. The market size and forecast for each of these segments have been provided
for the period from 2014 to 2024, along with their respective CAGRs for the forecast
period from 2016 to 2024, considering 2015 as the base year.
Based on distribution channel, the global cryptococcosis market is segmented as
hospital pharmacies, retail pharmacies, drug store, and mail order pharmacies. Retail
pharmacy was the largest segment of the global market in terms of revenue in 2015
and is expected to continue to dominate the market by 2024, which is attributed to
the increasing contribution of long term medication required for cryptococcosis
treatment. Online purchase of drugs has been highly popular in most of the
developed economies such as the U.S. and Japan.
Geographically, the global cryptococcosis market has been categorized into five
major regions and the key countries in the respective region: North America (U.S.
and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe),
Asia Pacific (India, Japan, China, Australia and Rest of Asia Pacific), Latin America
(Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South
Africa, GCC Countries, and Rest of Middle East & Africa).